Membership

Newsletters

July 2016 Newsletter

With the recent announcement that a first-line immunotherapy trial for non-small cell lung cancer (NSCLC) is positive for survival improvement, I can see the standard of care for lung cancer patients radically changing over the next few years.

June 2016 Newsletter

IASLC‘s Asia Pacific Lung Cancer Conference (APLCC) was held in mid-May in beautiful Chiang Mai, Thailand.

May 2016 Newsletter

This year’s European regional meeting, the European Lung Cancer Conference (ELCC), recently concluded in Geneva, Switzerland.

April 2016 Newsletter

How can the IASLC make the biggest impact on improving the quantity and quality of life of thoracic cancer patients across the world?

March 2016 Newsletter

The Santa Monica meeting has become a cornerstone of the regional IASLC meetings, and a forum for investigators to learn about the latest therapies and for companies to interact with investigators to plan the next generation of clinical trials in lung cancer.

February 2016 Newsletter

With the start of a new year, we see new opportunities on the horizon with lung cancer treatments and we must work to maximize their impact and potential. With the approval of alectinib and osimertinib, we continue to see the rapid rise in the options available to our patients, and your IASLC continues its commitment to educate the oncology community and patients on these new developments.

Pages